Last week, the Illinois Supreme Court held that a five-year statute of limitations applies to all claims under the Illinois Biometric Privacy Act (BIPA), further expanding the already broad scope and application of the Illinois statute.1
https://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.png00Kathleen Carlsonhttps://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.pngKathleen Carlson2023-02-10 11:05:132023-09-06 15:36:46Illinois Supreme Court Clarifies Statute of Limitations for Illinois Biometric Privacy Act Claims: Five Years
Healthcare providers, health plans, and technology companies that use mobile health apps to access, collect, share, use, or maintain information related to an individual’s health should take note of the recently issued Federal Trade Commission (FTC) Mobile Health App Interactive Tool. The purpose of the tool is to help mobile health developers determine the federal regulatory, privacy, and security laws and regulations that may apply to the use of a consumer’s health information, such as information related to diagnosis, treatment, fitness, wellness, or addiction. While the tool should not be considered legal advice and cannot guarantee compliance with legal requirements, it can help healthcare providers, health plans, and technology companies issue-spot to manage risk in this heavily regulated space.
https://datamatters.sidley.com/wp-content/uploads/sites/2/2022/10/MN-18359_Data-Matters_833x606-08.jpg607833Colleen Theresa Brownhttps://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.pngColleen Theresa Brown2023-02-07 15:02:142023-09-06 15:37:05New FTC Guidance for Mobile Health Apps
New measures for the security assessment of data transfers from China to other countries could make it harder for international pharma companies with China operations to transfer health data out of the country. Lianying Wang explains.
https://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.png00Lianying Wanghttps://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.pngLianying Wang2023-02-03 16:27:542023-09-06 15:37:33It Is Now More Difficult For International Pharma To Transfer Data Out Of China
On January 10, 2023, the Financial Industry Regulatory Authority (FINRA) published its 2023 Report on its Examination and Risk Monitoring Program (the Report).1 The 75-page Report includes four new topic areas for 2023: (1) manipulative trading, (2) fixed income — fair pricing, (3) fractional shares — reporting and order handling, and (4) Regulation SHO.
https://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.png00Andrew P. Blakehttps://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.pngAndrew P. Blake2023-01-31 11:31:162023-09-06 15:37:51FINRA Issues 2023 Report on Its Examination and Risk Monitoring Program
The EU Digital Markets Act (DMA) is set to revolutionize the way in which so-called ‘Big Tech’ is regulated in the EU, shifting toward ex-ante rulemaking and away from traditional after-the-fact enforcement. The DMA imposes a stringent regulatory regime on large online platforms (so-called “gatekeepers”) and gives the European Commission (Commission) new enforcement powers, including an ability to impose severe fines and remedies for noncompliance.
https://datamatters.sidley.com/wp-content/uploads/sites/2/2022/10/MN-18359_Data-Matters_833x606-10.jpg607834Ken Dalyhttps://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.pngKen Daly2023-01-24 12:05:532023-09-06 15:38:25Unpacking Digital Data Laws Across Europe: Addressing the Digital Markets Act
In 2022, many if not most pharmaceutical, medical device, and other life sciences companies established strategies to innovate digital health technology complementary to their existing strategic focus. The digital transformation of the life sciences industry is still widely unfolding across the marketplace. In 2023 and beyond, the race is on to launch the next generation of digital health technologies to innovate the delivery of therapies to patients. (more…)
https://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.png00Meenakshi Dattahttps://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.pngMeenakshi Datta2023-01-23 09:07:012023-09-06 15:38:43Digital Health Transformation: A Practical Guide for Life Sciences Companies
On 17 January 2023, the new Network and Information Systems Security Directive (“NIS2 Directive”), which is aimed at establishing a minimum level of cybersecurity standards across the EU and is set to replace its predecessor (the NIS or “NIS1 Directive”), entered into force. The new NIS2 Directive aims to further harmonize and strengthen cybersecurity and resilience throughout the EU in response to a continued increase in digitization and rise in cyber (and in particular ransomware) threats – which is estimated to have reached a total cost of €5.5 trillion at the end of 2020 (double the figure of 2015) and continues to rise in the EU and globally notably due to ongoing geopolitical conflicts in Ukraine and Russia. (more…)
The bankruptcy court presiding over the Chapter 11 cases of digital asset platform Celsius Network LLC and its affiliates (Celsius) issued a key ruling on January 4, 2023 (the Decision), by concluding that a significant portion of digital assets held in Celsius’ customer accounts are property of the debtors’ estates, and holders of such accounts accordingly are unsecured creditors.1 The digital assets at issue in the Decision were held under Celsius’ “Earn” program, pursuant to which the digital assets were not segregated or held in custody but used freely by Celsius to generate investment returns, and were subject to contract terms stating that the digital assets belonged to Celsius.
https://datamatters.sidley.com/wp-content/uploads/sites/2/2022/10/MN-18359_Data-Matters_833x606-15.jpg607834Teresa Wilton Harmonhttps://datamatters.sidley.com/wp-content/uploads/sites/2/2022/09/sidleyLogo-e1643922598198.pngTeresa Wilton Harmon2023-01-18 09:05:172023-09-06 15:39:24Celsius Bankruptcy Court Confirms That Customer Digital Assets Are Property of the Estate in Key Ruling
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
Illinois Supreme Court Clarifies Statute of Limitations for Illinois Biometric Privacy Act Claims: Five Years
Last week, the Illinois Supreme Court held that a five-year statute of limitations applies to all claims under the Illinois Biometric Privacy Act (BIPA), further expanding the already broad scope and application of the Illinois statute.1
(more…)
Kathleen Carlson
Chicago
kathleen.carlson@sidley.com
Lawrence P. Fogel
Chicago
lawrence.fogel@sidley.com
Geeta Malhotra
Chicago
gmalhotra@sidley.com
Stephen W. McInerney
Chicago
smcinerney@sidley.com
Andrew F. Rodheim
Chicago
arodheim@sidley.com
Carly R. Owens
New FTC Guidance for Mobile Health Apps
Healthcare providers, health plans, and technology companies that use mobile health apps to access, collect, share, use, or maintain information related to an individual’s health should take note of the recently issued Federal Trade Commission (FTC) Mobile Health App Interactive Tool. The purpose of the tool is to help mobile health developers determine the federal regulatory, privacy, and security laws and regulations that may apply to the use of a consumer’s health information, such as information related to diagnosis, treatment, fitness, wellness, or addiction. While the tool should not be considered legal advice and cannot guarantee compliance with legal requirements, it can help healthcare providers, health plans, and technology companies issue-spot to manage risk in this heavily regulated space.
(more…)
Colleen Theresa Brown
Washington, D.C.
cbrown@sidley.com
Meenakshi Datta
Chicago
mdatta@sidley.com
Sama E. Kahook
Washington, D.C.
Francesca R. Ozinal
Washington, D.C.
fozinal@sidley.com
It Is Now More Difficult For International Pharma To Transfer Data Out Of China
New measures for the security assessment of data transfers from China to other countries could make it harder for international pharma companies with China operations to transfer health data out of the country. Lianying Wang explains.
Lianying Wang
Beijing
lianying.wang@sidley.com
FINRA Issues 2023 Report on Its Examination and Risk Monitoring Program
On January 10, 2023, the Financial Industry Regulatory Authority (FINRA) published its 2023 Report on its Examination and Risk Monitoring Program (the Report).1 The 75-page Report includes four new topic areas for 2023: (1) manipulative trading, (2) fixed income — fair pricing, (3) fractional shares — reporting and order handling, and (4) Regulation SHO.
(more…)
Andrew P. Blake
Washington, D.C.
ablake@sidley.com
James Brigagliano
W. Hardy Callcott
San Francisco
wcallcott@sidley.com
Neal E. Sullivan
Washington D.C.
nsullivan@sidley.com
Corin R. Swift
New York
corin.swift@sidley.com
Lara C. Thyagarajan
New York
lthyagarajan@sidley.com
Paul M. Tyrrell
Boston
ptyrrell@sidley.com
Michael D. Wolk
Michael J. Ogershok
Washington D.C.
mogershok@sidley.com
Unpacking Digital Data Laws Across Europe: Addressing the Digital Markets Act
The EU Digital Markets Act (DMA) is set to revolutionize the way in which so-called ‘Big Tech’ is regulated in the EU, shifting toward ex-ante rulemaking and away from traditional after-the-fact enforcement. The DMA imposes a stringent regulatory regime on large online platforms (so-called “gatekeepers”) and gives the European Commission (Commission) new enforcement powers, including an ability to impose severe fines and remedies for noncompliance.
(more…)
Ken Daly
Brussels
kdaly@sidley.com
Monika Zdzieborska
London
mzdzieborska@sidley.com
Bethany Wise
London
bwise@sidley.com
Anna Kubinska
London
akubinska@sidley.com
Digital Health Transformation: A Practical Guide for Life Sciences Companies
In 2022, many if not most pharmaceutical, medical device, and other life sciences companies established strategies to innovate digital health technology complementary to their existing strategic focus. The digital transformation of the life sciences industry is still widely unfolding across the marketplace. In 2023 and beyond, the race is on to launch the next generation of digital health technologies to innovate the delivery of therapies to patients.
(more…)
Meenakshi Datta
Chicago
mdatta@sidley.com
Deeona R. Gaskin
Washington D.C.
dgaskin@sidley.com
Eva von Mühlenen
Geneva
emuhlenen@sidley.com
EU Publishes New NIS2 Cyber Directive Imposing Liability and Obligations on Senior Management
On 17 January 2023, the new Network and Information Systems Security Directive (“NIS2 Directive”), which is aimed at establishing a minimum level of cybersecurity standards across the EU and is set to replace its predecessor (the NIS or “NIS1 Directive”), entered into force. The new NIS2 Directive aims to further harmonize and strengthen cybersecurity and resilience throughout the EU in response to a continued increase in digitization and rise in cyber (and in particular ransomware) threats – which is estimated to have reached a total cost of €5.5 trillion at the end of 2020 (double the figure of 2015) and continues to rise in the EU and globally notably due to ongoing geopolitical conflicts in Ukraine and Russia. (more…)
William RM Long
London
wlong@sidley.com
Lauren Cuyvers
Brussels
lcuyvers@sidley.com
Matthias Bruynseraede
London
mbruynseraede@sidley.com
Eleanor Oates
London
eoates@sidley.com
Celsius Bankruptcy Court Confirms That Customer Digital Assets Are Property of the Estate in Key Ruling
The bankruptcy court presiding over the Chapter 11 cases of digital asset platform Celsius Network LLC and its affiliates (Celsius) issued a key ruling on January 4, 2023 (the Decision), by concluding that a significant portion of digital assets held in Celsius’ customer accounts are property of the debtors’ estates, and holders of such accounts accordingly are unsecured creditors.1 The digital assets at issue in the Decision were held under Celsius’ “Earn” program, pursuant to which the digital assets were not segregated or held in custody but used freely by Celsius to generate investment returns, and were subject to contract terms stating that the digital assets belonged to Celsius.
(more…)
Teresa Wilton Harmon
Chicago
tharmon@sidley.com
Stephen E. Hessler
New York
shessler@sidley.com
Lilya Tessler
Dallas, Miami
ltessler@sidley.com
Dennis M. Twomey
Chicago
dtwomey@sidley.com
Allison Ross Stromberg
Upcoming Events
Resources
Meet the Team
Kwaku A. Akowuah
kakowuah@sidley.com
Sheila A.G. Armbrust
sarmbrust@sidley.com
Francesca Blythe
fblythe@sidley.com
Colleen Theresa Brown
ctbrown@sidley.com
Thomas D. Cunningham
tcunningham@sidley.com
Sharon R. Flanagan
sflanagan@sidley.com
David A. Gordon
dgordon@sidley.com
Tomoki Ishiara
tishiara@sidley.com
Amy P. Lally
alally@sidley.com
David C. Lashway
dlashway@sidley.com
William RM Long
wlong@sidley.com
Joan M. Loughnane
jloughnane@sidley.com
Geeta Malhotra
gmalhotra@sidley.com
Rollin A. Ransom
rransom@sidley.com
Alan Charles Raul
araul@sidley.com
Jennifer B. Seale
jseale@sidley.com
Yuet Ming Tham
ytham@sidley.com
Jonathan M. Wilan
jwilan@sidley.com
John W. Woods Jr.
jwoods@sidley.com